U54 grant is supported by the National Cancer Institute (NCI) and the Fogarty International Center (FIC) of the National Institutes of Health under grant number U54CA221205.The award is coordinated by the NCI Office of HIV and AIDS Malignancy, in collaboration with the Fogarty International Centre, to support research on Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria aimed at identifying DNA methylation signatures and other epigenetic biomarkers specific to HIV-associated Hepatocellular carcinoma (HCC) and cervical cancer. The consortium will provide training and mentoring opportunities for Nigerian investigators conducting molecular epidemiology studies with a focus on epigenetic biomarkers. It will also establish four shared core facilities; one core dedicated to Administration, another to biomedical informatics and statistics, and the other focused on pathology and genomics.